Physician profile
Casey Clark
NPI 1518308923
$1,253.87
in general payments reported to CMS, 2019-2025
18 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $202 · 2023: $262 · 2024: $276 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $416.86 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $223.12 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $135.87 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $103.08 | 2022-2025 | Farxiga, Airsupra |
| Otsuka America Pharmaceutical, INC. | $72.98 | 2022-2025 | Rexulti |
| Exact Sciences Corporation | $44.87 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $39.10 | 2025 | Cobenfy |
| Pfizer INC. | $33.54 | 2023-2024 | |
| Irhythm Technologies, INC. | $26.53 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $22.47 | 2025 | Wavewriter Alpha Prime 16 |
| Viiv Healthcare Company | $20.85 | 2025 | Apretude |
| Abbott Laboratories | $20.32 | 2023 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.06 | 2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $17.61 | 2021 | |
| Amgen INC. | $16.96 | 2024 | Otezla, Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.40 | 2021 | |
| Amarin Pharma, INC. | $14.39 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.